Skip to main content

J&J To Pay $117M To Settle 41 States Mesh Lawsuit

J&J To Pay $117M To Settle 41 States Mesh Lawsuit

J&J To Pay $117M To Settle 41 States Mesh Lawsuit

Introduction

On Thursday, New York Attorney General Letitia James and 41 other state AGs resolved the transvaginal mesh lawsuit involving J&J (Johnson & Johnson) and their subsidiary Ethicon, Inc. for $117 million.

The defendants were facing allegations for hiding the risks associated with its pelvic mesh products, which support women's weakening pelvic organs. The court papers further stated that the companies should now impart the irreversible risks including, chronic pain,  inflammation, incontinence, painful sex, and scarring. The defendants are also barred from telling about its FDA approval, which was initially done in 2002, and now has been told to stop selling “due to safety concerns.”

Around four million women have vaginal mesh implants, and more than 150,000 developed complications associated with it. There are in all 7 MDLs to handle Transvaginal Mesh Litigations, which are being overseen by U.S. District Judge Joseph R. Goodwin.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!